Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata severity is influenced by factors like long disease duration, relapses, treatment response, and mental health, leading to the creation of a new severity measurement tool.

Clinicians should use evidence-based tools and consider mental health when assessing alopecia areata to guide treatment.

New tools help doctors better assess and treat alopecia areata in kids by considering more than just hair loss.

Early diagnosis and treatment of alopecia areata in children is crucial to prevent severe progression.

Higher inflammation markers are linked to more severe alopecia areata.

Higher IL-17A levels indicate more severe alopecia areata.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Alopecia Areata significantly lowers quality of life and current treatments are inadequate, highlighting a need for better therapies and standardized treatment protocols.

Depression severity is not linked to PCOS markers like BMI, insulin resistance, or testosterone levels.

Alopecia areata severely impacts quality of life, causing anxiety, depression, and work impairment.

Upadacitinib improved multiple immune-related conditions in one patient.

Alopecia Areata significantly reduces quality of life, especially in women, long-term sufferers, and severe cases.

Alopecia areata significantly increases anxiety, depression, and reduces quality of life.

Low-dose acitretin helps nail psoriasis, stem cells may treat scarring alopecia, Chinese men have lower baldness rates, lateral foldplasty is good for ingrown toenails, hair diameter helps diagnose female baldness, childhood trauma linked to alopecia areata, certain hair-weaving leads to scalp conditions in African American women, and new methods for hair research and understanding hair and sweat gland development were introduced.

There is a significant need for better-validated quality of life tools in dermatology.

Higher ACE2 levels in certain tissues may worsen COVID-19 in people with other health issues, especially older adults.

Higher levels of CCL7 are linked to more severe hair loss in alopecia areata patients.

Corticosteroids may not effectively control oxidative stress in alopecia areata, possibly leading to relapses.

Higher IL-21 levels may help predict alopecia areata activity.

Alopecia areata treatment varies, with no optimal method established yet.

Higher stress levels may worsen alopecia areata, suggesting stress management is important for treatment.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Hormonal therapies are safe and effective for treating acne in female adolescents, with specific treatments for those with endocrine disorders.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

High levels of IL6 and CRP, and low levels of vitamin D, might be indicators of alopecia areata.

The Dermatology Life Quality Index is reliable and consistent but needs more diverse participant studies.

Prolactin affects skin health and may lead to new treatments for skin and hair issues.

The Thai version of the Family Dermatology Life Quality Index is a reliable and valid tool for assessing the quality of life of patients' families.

Diet can influence inflammatory skin diseases.